Contrave ER 8-90 MG tablet 120S
Ended Awarded Last action
- Contract number
- SPE2DR26FJB3Z
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,707
Award facts
- Contract value 100% obligated
- $13,707.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $13,707.16 to AmerisourceBergen Drug Corp for the supply of Contrave ER 8-90 mg tablets (120 count) on November 28, 2025, with an ultimate completion date of December 1, 2025. This firm fixed-price, non-set-aside contract is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime contract vehicle valued through December 2026 that provides comprehensive pharmaceutical and medical supply support to military healthcare systems globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, routinely fulfills competitively awarded delivery orders for diverse pharmaceutical products and medical supplies supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Contrave is a weight-management medication combining naltrexone and bupropion, indicating this order supports pharmaceutical needs within military or veteran healthcare networks. The company's extensive federal contract portfolio demonstrates its capability to meet federal procurement requirements across multiple therapeutic domains, from specialty medications and vaccines to medical devices and diagnostic supplies.
Quick answers
Who was awarded contract SPE2DR26FJB3Z?
SPE2DR26FJB3Z was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 28, 2025.
How much is contract SPE2DR26FJB3Z worth?
The government has obligated $13,707 on SPE2DR26FJB3Z.
Is contract SPE2DR26FJB3Z an order under another contract?
Yes. SPE2DR26FJB3Z is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJB3Z competed?
The extent of competition for SPE2DR26FJB3Z was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award